FarFaR
FarFaR is a joint digital repository of the all departments in University of Belgrade - Faculty of Pharmacy. FarFaR provides open access to the publications, as well as to other outputs of the research projects implemented in this institution.
The software platform of the repository is adapted to the modern standards applied in the dissemination of scientific publications and is compatible with international infrastructure in this field.
You may use the external application Authors, Projects, Publications (APP) to browse and search authors and funding information. APP also enables metadata export and displays Altmetric scores and Dimensions, Scopus and Web of Science citation counts.
Institutions/Communities
Select an institution/community
Recently Added
-
The Comparative Analysis of the Impact of N-Acetyl-L-Cysteine and its Combination with Propolis on Quality-of-Life in Patients with Acute Bronchitis
(Association of Pharmaceutical Teachers of India, 2024) -
What is the Current Clinical Impact of the CYP2CTG Haplotype?
(John Wiley and Sons Inc, 2024) -
Intraoral administration of probiotics and postbiotics: An overview of microorganisms and formulation strategies
(Faculdade de Ciencias Farmaceuticas, 2024) -
Examination of the effects of X-ray phase contrast imaging dose on DNA in mesenchymal stem cells by comet assay
(Savez hemijskih inženjera, Beograd, 2024) -
Normal human microbiota and dysbiosis - implications for health and disease / Normalna ljudska mikrobiota i disbioza - implikacije po zdravlje i bolest
(Beograd : Savez farmaceutskih udruženja Srbije, Beograd : Univerzitet u Beogradu - Farmaceutski fakultet, 2024) -
Quinoline-based thiazolyl-hydrazones target cancer cells through autophagy inhibition
(John Wiley and Sons Inc, 2024) -
Understanding hemoglobin contribution to high-dose methotrexate disposition—population pharmacokinetics in pediatric patients with hematological malignancies
(Springer Science and Business Media Deutschland GmbH, 2024) -
Evaluation of novel compounds as anti-bacterial or anti-virulence agents
(Frontiers Media SA, 2024)